[Sepsis and multi-organ failure].
Okajima
Kenji
K
Department of Laboratory Medicine, Kumamoto University School of Medicine.
D000818:Animals; D000991:Antithrombins / Q000627:therapeutic use; D004211:Disseminated Intravascular Coagulation / Q000209:etiology; D004730:Endothelium, Vascular / Q000166:cytology / Q000473:pathology; D006801:Humans; D008833:Microcirculation; D009000:Monocytes / Q000502:physiology; D009102:Multiple Organ Failure / Q000188:drug therapy / Q000209:etiology*; D018375:Neutrophil Activation; D011379:Prognosis; D011486:Protein C / Q000627:therapeutic use; D012128:Respiratory Distress Syndrome / Q000209:etiology; D018805:Sepsis / Q000150:complications* / Q000276:immunology; D015843:Serpins / Q000627:therapeutic use; D012772:Shock, Septic / Q000209:etiology; D013927:Thrombosis / Q000209:etiology; D014409:Tumor Necrosis Factor-alpha / Q000502:physiology
D000991:Antithrombins; D011486:Protein C; D015843:Serpins; D014409:Tumor Necrosis Factor-alpha